Assessment of Interferential Currents Therapy Efficacy in Management of Primary Nocturnal Enuresis in 5-15 Years Old Children: A Randomized Clinical Trial
|Parviz Yazdanpanah1, Mousavizadeh Ali2and Sadrollah Mehrabi3*|
|1Department of PhysicalMedicine & Rehabilitation, Yasuj University of Medical Sciences, Yasuj, Iran|
|2Department of Epidemiology, Health and Nutrition College, Shiraz University of Medical Science, Iran|
|3Department of Urology, Yasuj University of Medical Sciences, Yasuj, Iran|
|Corresponding Author :||Sadrollah Mehrabi
Department of Urology
Yasuj University of Medical Sciences
E-mail: [email protected]
|Received February 13, 2012; Accepted March 13, 2012; Published March 16, 2012|
|Citation: Yazdanpanah P, Ali M, Mehrabi S (2012) Assessment of Interferential Currents Therapy Efficacy in Management of Primary Nocturnal Enuresis in 5-15 Years Old Children: A Randomized Clinical Trial. J Nov Physiother 2:109. doi: 10.4172/2165-7025.1000109|
|Copyright: © 2012 Yazdanpanah P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
Introduction: Nocturnal enuresis affects about 15 percent of 5 years old children and because of its social (psychological) problems, it must be treated. Different treatment modalities such as imipramine, desmopressin, bed alarm have been used but applying of new and effective modalities can be an appropriate view. The aim of this study was to compare efficacy of interferential currents (IFC) with nasal spray of desmopressin in treatment of primary nocturnal enuresis of 5-15 years-old children.
Methods: This study was a randomized, clinical trial in which 39 patients with primary nocturnal enuresis received desmopressin (20 μg/day ) for 3weeks and if was responsive, leave off gradually in six months and 36 patients were selected randomly by simple randomization for IFC therapy (5 times /week, 20 minutes / session, up to 15 sessions). Efficacy of treatment was evaluated after accomplishment of therapeutic sessions and recurrence rate was evaluated one month later.
Results: In IFC group, complete response was observed in 25%, partial response in 36.1% and 38.9% had no response. In desmopressin group, response was observed in 87.2%, and 12.8% had no response (Risk ratio =2.4, 95% confidence interval (1.32-4.32)). The recurrence rate in IFC and desmopressin were 61% and 87.2%, respectively. Therapeutic side effects were not observed in any of patients (Risk Ratio=0.7, 95%CI (0.53-0.94)).
Conclusion: Desmopressin and IFC are effective and safe modalities for treatment of primary nocturnal enuresis of children. Although desmopressin has more efficacy but IFC has less recurrence rate